This Innovative Biotech Firm Is Changing The Way We See Medication

Sign up for this week’s All Access giveaway here!

Dr. Lynn Kirkpatrick, CEO of Ensysce Biosciences ENSC, was a guest on Benzinga’s All Access on Sep 23, 2022. 

Ensysce is a biotech company committed to stemming the prescription drug abuse epidemic. The company focuses on innovative chemistry to meet research & development goals. Its approach is to look at drug delivery from a different view, using sophisticated chemistry to change the mode of activation rather than just modify a formulation.

Watch the full interview here:

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.